GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Propanc Biopharma PPCB · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.76

-0.56%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Propanc Biopharma

Our reporting

We have not reported on Propanc Biopharma yet.

Next results

13 Nov 2026

Due on 13 Nov 2026.

Past results

Reported against what analysts expected

5 Oct 202625 Sept 202614 May 202617 Feb 202614 Nov 202529 Sept 2025
Earnings per share-40.70-40.70-7.00-0.30-0.39-0.35

Key events

  1. 26 Oct 202610-to-1 reverse split
  2. 18 May 202625-to-1 reverse split
  3. 29 Jan 202560000-to-1 reverse split
  4. 23 May 20231000-to-1 reverse split
  5. 19 Nov 20201000-to-1 reverse split
  6. 24 Jun 2019500-to-1 reverse split

Propanc Biopharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.